Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Amylin Pharmaceuticals
company
About
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
- 5001 - 10000
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology
- Founded date
- Jan 1, 1987
- Number Of Employee
- 5001 - 10000
- Operating Status
- Active
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.Develops a line of diagnostic and therapeutic products for diabetics.Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Amylin Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 1990 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 1990 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amylin Pharmaceuticals is funded by 1 investors.
Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Sequoia Capital
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
